We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$53.6B
AUM Growth
+$2.66B
(+5.2%)
Cap. Flow
+$86.8M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
37.17%
Holding
821
New
56
Increased
227
Reduced
258
Closed
253
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$86.2M |
| 2 |
Alcon
ALC
|
+$81.8M |
| 3 |
NVIDIA
NVDA
|
+$76M |
| 4 |
Corning
GLW
|
+$50.4M |
| 5 |
UnitedHealth
UNH
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$67.4M |
| 2 |
Factset
FDS
|
+$62M |
| 3 |
Euronet Worldwide
EEFT
|
+$42.3M |
| 4 |
Bank of America Series L
BAC.PRL
|
+$39.5M |
| 5 |
OPLN
Openlane
OPLN
|
+$31.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 17.74% |
| 3 | Financials | 11.65% |
| 4 | Healthcare | 11.2% |
| 5 | Communication Services | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Kinsale Capital Group
KNSL
$8.56B
| $51.7M | 0.1% |
564,825
+12,064
| +2% | +$963K |
|
77
McCormick & Company Non-Voting
MKC
$14.2B
| $51.5M | 0.1% |
664,720
+42,976
| +7% | +$3.31M |
|
78
Planet Fitness
PLNT
$4B
| $51.1M | 0.1% |
705,721
-93,641
| -12% | -$7.06M |
|
79
HubSpot
HUBS
$10.2B
| $51M | 0.1% |
299,158
-12,417
| -4% | -$2.17M |
|
80
Columbia Sportswear
COLM
$2.92B
| $50.4M | 0.09% |
503,108
+7,779
| +2% | +$772K |
|
|
LHCG
81
DELISTED
LHC Group LLC
LHCG
| $50M | 0.09% |
418,136
+95,569
| +30% | +$10.8M |
|
82
Guidewire Software
GWRE
$13.9B
| $49.9M | 0.09% |
491,885
-49,339
| -9% | -$5.03M |
|
83
Nomad Foods
NOMD
$1.66B
| $49.5M | 0.09% |
2,318,075
-16,873
| -0.7% | -$354K |
|
84
RBC Bearings
RBC
$18B
| $48.9M | 0.09% |
292,862
-45,770
| -14% | -$6.48M |
|
85
Merit Medical Systems
MMSI
$5.26B
| $48.5M | 0.09% |
814,974
+100,008
| +14% | +$5.73M |
|
|
WNS
86
DELISTED
WNS Holdings
WNS
| $45.9M | 0.09% |
775,177
+91,353
| +13% | +$5.13M |
|
|
EVOP
87
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $45.9M | 0.09% |
1,455,011
+66,013
| +5% | +$1.93M |
|
|
CHX
88
DELISTED
ChampionX
CHX
| $45.6M | 0.09% |
1,358,260
+297,969
| +28% | +$10.8M |
|
89
Cogent Communications
CCOI
$479M
| $44.7M | 0.08% |
753,474
-97,042
| -11% | -$5.57M |
|
90
Silicon Laboratories
SLAB
$7.23B
| $44.5M | 0.08% |
430,680
+4,628
| +1% | +$447K |
|
91
Mercado Libre
MELI
$91.5B
| $44.5M | 0.08% |
72,725
+6,726
| +10% | +$3.74M |
|
92
Laureate Education
LAUR
$5.28B
| $44.4M | 0.08% |
2,828,574
+222,909
| +9% | +$3.55M |
|
93
Freshpet
FRPT
$3.22B
| $43.9M | 0.08% |
963,981
+198,467
| +26% | +$8.99M |
|
|
MDSO
94
DELISTED
Medidata Solutions, Inc.
MDSO
| $42.8M | 0.08% |
472,523
-163,226
| -26% | -$14.3M |
|
|
CTLT
95
DELISTED
CATALENT, INC.
CTLT
| $42.6M | 0.08% |
785,987
+158,861
| +25% | +$7.27M |
|
|
INXN
96
DELISTED
Interxion Holding N.V.
INXN
| $40.9M | 0.08% |
537,689
+26,335
| +5% | +$1.88M |
|
97
Icon
ICLR
$12.6B
| $40.3M | 0.08% |
261,887
+13,468
| +5% | +$1.89M |
|
98
Wingstop
WING
$3.19B
| $40.1M | 0.07% |
423,353
-66,690
| -14% | -$5.43M |
|
99
Goosehead Insurance
GSHD
$2.33B
| $39.8M | 0.07% |
832,808
+116,776
| +16% | +$4.07M |
|
100
EOG Resources
EOG
$71.3B
| $39.6M | 0.07% |
424,827
+27,229
| +7% | +$2.53M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2019 Portfolio in Review
As of Q2 2019, Loomis, Sayles & Company held 821 positions worth $53.6B, up 5.2% from $50.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Loomis, Sayles & Company's Q2 2019 filing shows 56 new, 227 increased, 258 reduced and 253 closed positions. Its largest new stake was Alcon: 1,393,674 shares worth $86.5M. The largest sale was Novartis, an estimated $67.4M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q2 2019 buy was Alcon: 1,393,674 shares worth $86.5M.
- Loomis, Sayles & Company added most to Bristol-Myers Squibb in Q2 2019, an estimated $86.2M increase.
- Loomis, Sayles & Company's biggest Q2 2019 reduction was Novartis, cutting an estimated $67.4M.
- Loomis, Sayles & Company fully exited RingCentral in Q2 2019, selling an estimated $30.4M.
- Loomis, Sayles & Company's ten largest holdings make up 37% of its $53.6B portfolio in Q2 2019.
- Loomis, Sayles & Company opened 56 new positions and closed 253 in Q2 2019.
- Loomis, Sayles & Company's portfolio value rose 5.2% quarter-over-quarter to $53.6B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.